Harvard Psychopharmacology A Master Class 2026

• Target Audience: psychiatrists, nurse practitioners, and primary care physicians
• Sample video: contact me for sample video
• Information:

1. Overview

2. Learning Objectives

Understand the underlying neurobiology of psychiatric disorders to inform targeted psychopharmacological interventions.

Evaluate and implement advanced therapeutic strategies for difficult-to-treat conditions, including refractory depression and complex bipolar disorder.

Assess emerging treatments, such as neuromodulation approaches, psychedelics for PTSD, and the role of Apps/AI in psychiatric care.

Tailor psychopharmacologic treatments for specific populations, including geriatric, pediatric, perinatal, and substance use disorder patients.

3. Target Audience

Best for psychiatrists, nurse practitioners, and primary care physicians who want key updates on advanced psychopharmacology and novel therapeutics.

4. Topics

Update on the Neurobiology for the Practicing Clinician Understanding Brain Function and its Clinical Relevance

Update on the Development of Antidepressant for Refractory Depression

Treatment of Bipolar Disorders Rational Polypharmacy and Bipolar Depression

Psychopharmacology in Perinatal Mood and Anxiety Disorders

Psychopharmacologic Approaches in Childhood and Adolescents Affective Disorders

Panel Discussion 1

Current and Emerging Neuromodulation Approaches Update for Prescribers

Psychopharmacology in Geriatrics and Neuropsychiatry Population

Therapeutic Approaches to the Difficult Patient Difficult-to-Treat Depression

Panel Discussion 2

Neurobiology and treatment of Sleep in Psychiatric Disorders

Apps and AI as Therapeutics

Mechanisms of Psychedelics and Their Potential Treatment for PTSD

Panel Discussion 3

Effective Treatment of Substance Use Disorders

Anxiety Mechanisms, Treatment of Anxiety Spectrum Disorders & New Benzodiazepine Data

The Status of Laboratory Testing to Predict Antidepressant Response Problems and Promises

Panel Discussion 4